Project Grant R25DA066440
Award Date 9/1/26
Completion Date 5/31/30
Dollars Obligated $248K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Vermillion, SD 57069, USA
Similar Awards
- The Centers for Disease Control and Prevention awarded Health Connect of South Dakota, Inc. $125,000 under the Drug-Free Communities Support Program (CFDA 93.276) on July 1, 2026. The Sioux Empire Coalition, in partnership with Health Connect of South Dakota and the Carroll Institute, will deliver the FUSE (Fueling Unity for Substance Education) initiative to prevent youth substance use in rural South Dakota communities: Garretson in Minnehaha County and Tea and Harrisburg in Lincoln County. The...
- The National Institute on Drug Abuse awarded The Medical University of South Carolina $675,129 on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to evaluate an integrated, trauma-focused intervention for adolescents with co-occurring substance use disorders and post-traumatic stress disorder. The funded research will assess the safety, feasibility, and efficacy of Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure adapted for...
- The National Institute on Drug Abuse awarded The Medical University of South Carolina $354,135 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to deliver the SEX DIFFERENCES EDUCATION IN SUBSTANCE USE DISORDERS (SEEDS) program, a training and career development initiative for early-stage investigators. SEEDS will provide comprehensive mentored pilot project research experiences, formal didactic training in research methodology (including responsible conduct of...
- The National Institute on Drug Abuse awarded The Medical University of South Carolina $906,000 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and implement a training curriculum for Emergency Psychiatric Assessment, Treatment, and Healing (EMPATH) unit personnel focused on acute management of opioid use disorder with emphasis on medication for opioid use disorder initiation using buprenorphine. Phase 1 (R-61) of the project will focus on curriculum...
- The National Institute on Drug Abuse awarded The Medical University of South Carolina $211,680 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support research investigating neurobiological mechanisms underlying reward-cue associations and relapse-like behavior in substance use disorders. The project, NPAS4+ Neuronal Ensembles: Mechanisms of Reward-Cue Associations and Relapse-Like Behavior, examines how neuronal activity in the nucleus accumbens...
- The National Institute on Drug Abuse awarded Research Foundation For Mental Hygiene, Inc. $1,091,599 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test E-ConnectYA, a system-level intervention tailored to engage criminal-legal-system-involved young adults through supportive employment while addressing overdose risk, suicide risk, and substance use and mental health treatment needs. The five-year study, which runs through January 31, 2031,...
- The National Institute on Drug Abuse awarded the University of California, San Diego $879,000 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate a novel episode-based paradigm for studying how family processes drive adolescent substance use. The project will collect real-time, real-world intensive longitudinal data on discrete parent and youth behaviors before and after episodes of substance use from 90 adolescents who use substances....
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the University of California, San Diego three hundred thousand dollars on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to develop and deliver comprehensive graduate education on substance use disorders. The award funds the UC San Diego Comprehensive Graduate Education for Substance Use Disorders...
- The National Institute on Drug Abuse awarded the University of California, San Diego $2,543,114 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to establish the Polysubstance Addiction Research Center, a five-year research initiative addressing polysubstance use disorders through integrated behavioral, molecular, circuit, and immunometabolic investigation. The center will conduct three primary research projects: brain connectomic analysis, brain...
- The National Institute on Drug Abuse awarded the University of South Carolina $631,513 on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate modifiable factors in the HIV care continuum for people with HIV affected by substance use and mental health comorbidities. The project uses real-world multiple linked datasets—including Enhanced HIV/AIDS Surveillance (E-HARS), electronic health records, Department of Mental Health data, Department of...